During the AGM a shareholder asked why Virbac appeared to...

  1. 2,309 Posts.
    lightbulb Created with Sketch. 17
    During the AGM a shareholder asked why Virbac appeared to hogging the credit for Stelfonta, as there was not even a mention of Qbiotics on the label. It was a query that was swiftly deflected. Perhaps Qbiotics needs to take a lesson from the following, particularly as it is collaborating with Merck

    Pandion's secret to moving a $65M Merck offer to a $1.9B done deal in a year? Just keep saying no | FierceBiotech

    https://www.fiercebiotech.com/biotech/pandion-s-secret-to-moving-a-65m-merck-offer-to-a-1-9b-done-deal-a-year-just-keep-saying-no
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.